Jean Pierre Bizzari Adc Therapeutics Sa (ADCT) insider trading activity

Jean Pierre Bizzari is Director of ADC Therapeutics SA. Currently has a direct ownership of 106,902 shares of ADCT, which is worth approximately $288,635. The most recent transaction as insider was on Jun 13, 2025, when has been sold 12,600 shares (Common Shares) at a price of $3.58 per share, resulting in proceeds of $45,108. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 107K

34.46% 3M change

34.46% 12M change

Total Value Held $288,635

JEAN-PIERRE BIZZARI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2025	SELL Payment of exercise price or tax liability	$45,108 $3.58 p/Share	12,600 Reduced 10.54%	106,902 Common Shares
Jun 03 2025	BUY Grant, award, or other acquisition	-	40,000 Added 25.08%	119,502 Common Shares
Jun 17 2024	SELL Open market or private sale	$20,215 $2.89 p/Share	6,995 Reduced 8.09%	79,502 Common Shares
Jun 13 2024	BUY Grant, award, or other acquisition	-	40,000 Added 31.62%	86,497 Common Shares

Also insider at

HALO

HALOZYME THERAPEUTICS, INC. Healthcare

APRE

Aprea Therapeutics, Inc. Healthcare

Director